234
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Reliability and accuracy of blue light imaging for staging of intestinal metaplasia in the stomach

ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1301-1305 | Received 05 Sep 2019, Accepted 17 Oct 2019, Published online: 03 Nov 2019

References

  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
  • Areia M, Spaander MC, Kuipers EJ, et al. Endoscopic screening for gastric cancer: a cost-utility analysis for countries with an intermediate gastric cancer risk. United Euro Gastroenterol J. 2018;6(2):192–202.
  • Marques-Silva L, Areia M, Elvas L, et al. Prevalence of gastric precancerous conditions: a systematic review and meta-analysis. Euro J Gastroenterol Hepatol. 2014;26(4):378–387.
  • Pimentel-Nunes P, Libânio D, Marcos-Pinto R, et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy. 2019;51(4):365–388.
  • Rugge M, Meggio A, Pennelli G, et al. Gastritis staging in clinical practice: the OLGA staging system. Gut. 2007;56(5):631–636.
  • Guarner J, Herrera-Goepfert R, Mohar A, et al. Interobserver variability in application of the revised Sydney classification for gastritis. Hum Pathol. 1999;30(12):1431–1434.
  • Dinis-Ribeiro M, Areia M, de Vries AC, et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy. 2012;44(1):74–94.
  • Rees CJ, Ngu WS, Regula J, et al. European Society of Gastrointestinal Endoscopy - establishing the key unanswered research questions within gastrointestinal endoscopy. Endoscopy. 2016;48(10):884–891.
  • Lage J, Uedo N, Dinis-Ribeiro M, et al. Surveillance of patients with gastric precancerous conditions. Best Pract Res Clin Gastroenterol. 2016;30(6):913–922.
  • Lage J, Pimentel-Nunes P, Figueiredo PC, et al. Light-NBI to identify high-risk phenotypes for gastric adenocarcinoma: do we still need biopsies? Scand J Gastroenterol. 2016;51(4):501–506.
  • Pimentel-Nunes P, Libânio D, Lage J, et al. A multicenter prospective study of the real-time use of narrow-band imaging in the diagnosis of premalignant gastric conditions and lesions. Endoscopy. 2016;48(8):723–730.
  • Kikuste I, Marques-Pereira R, Monteiro-Soares M, et al. Systematic review of the diagnosis of gastric premalignant conditions and neoplasia with high-resolution endoscopic technologies. Scand J Gastroenterol. 2013;48(10):1108–1117.
  • Dias-Silva D, Pimentel-Nunes P, Magalhães J, et al. The learning curve for narrow-band imaging in the diagnosis of precancerous gastric lesions by using Web-based video. Gastrointest Endosc. 2014;79(6):910–920.
  • Esposito G, Pimentel-Nunes P, Angeletti S, et al. Endoscopic grading of gastric intestinal metaplasia (EGGIM): a multicenter validation study. Endoscopy. 2019;51(06):515–521.
  • Kato M, Kaise M, Yonezawa J, et al. Magnifying endoscopy with narrow-band imaging achieves superior accuracy in the differential diagnosis of superficial gastric lesions identified with white-light endoscopy: a prospective study. Gastrointest Endosc. 2010;72(3):523–529.
  • Chen H, Liu Y, Lu Y, et al. Ability of blue laser imaging with magnifying endoscopy for the diagnosis of gastric intestinal metaplasia. Lasers Med Sci. 2018;33(8):1757–1762.
  • Chen H, Wu X, Liu Y, et al. Blue laser imaging with acetic acid enhancement improved the detection rate of gastric intestinal metaplasia. Lasers Med Sci. 2019;34(3):555–559.
  • Ezoe Y, Muto M, Uedo Doyama H, et al. Magnifying narrowband imaging is more accurate than conventional white-light imaging in diagnosis of gastric mucosal cancer. Gastroenterology. 2011;141(6):2017.e3–2025.e3.
  • Yao K, Iwashita A, Kikuchi Y, et al. Novel zoom endoscopy technique for diagnosis of small flat gastric cancer: a prospective, blind study. Clin Gastroenterol Hepatol. 2007;5(7):869–878.
  • Kimura-Tsuchiya R, Dohi O, Fujita Y, et al. Magnifying endoscopy with blue laser imaging improves the microstructure visualization in early gastric cancer: comparison of magnifying endoscopy with narrow-band imaging. Gastroenterol Res Pract. 2017;2017:8303046.
  • Dohi O, Yagi N, Yoshida S, et al. Magnifying blue laser imaging versus magnifying narrow-band imaging for the diagnosis of early gastric cancer: a prospective, multicenter, comparative study. Digestion. 2017;96(3):127–134.
  • Dohi O, Yagi N, Naito Y, et al. Blue laser imaging-bright improves the real-time detection rate of early gastric cancer: a randomized controlled study. Gastrointest Endosc. 2019;89(1):47–57.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.